Home/Filings/8-K/0001213900-26-001799
8-K//Current report

Trailblazer Merger Corp I 8-K

Accession 0001213900-26-001799

$TBMCCIK 0001934945operating

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 4:19 PM ET

Size

256.0 KB

Accession

0001213900-26-001799

Research Summary

AI-generated summary of this filing

Updated

Trailblazer Merger Corp I Extends SPAC Combination Deadline to Jan 31, 2026

What Happened

  • Trailblazer Merger Corp I (TBMC) filed an 8-K reporting it funded an approved extension of its SPAC business combination period by depositing $11,648.56 into its trust account, extending the deadline to complete an initial business combination from December 31, 2025 to January 31, 2026. The company previously held an annual meeting on September 29, 2025 to consider amending its charter to extend the outside date from September 30, 2025 to March 30, 2026 and to permit the board to add one-month extensions (up to six months total) without another shareholder vote.

Key Details

  • Deposit to Trust Account: $11,648.56 (extends combination deadline 1 month to Jan 31, 2026).
  • Prior corporate actions: Annual meeting on September 29, 2025 considered charter amendment to extend deadline to March 30, 2026 and allow up to six one-month board-approved extensions.
  • Merger arrangement: On July 22, 2024, Trailblazer Merger Corporation I entered into a merger agreement to combine with Cyabra Strategy Ltd.; the surviving public company is expected to be renamed “Cyabra, Inc.”
  • Regulatory filings: Holdings filed a registration statement on Form S-4 (includes a preliminary proxy statement/prospectus); a definitive proxy/prospectus will be mailed once effective and shareholders will vote on the merger.

Why It Matters

  • The one-month funding extension gives TBMC and the proposed target (Cyabra Strategy Ltd.) additional time to satisfy closing conditions and complete the merger process without immediate liquidation.
  • The filing confirms the ongoing merger process (S-4/proxy to follow) and highlights material risks and forward‑looking statements disclosed to investors, including the possibility the transaction may not close, timing uncertainty, and other risks that could affect the value of Parent’s securities.
  • Shareholders should watch for the S-4/definitive proxy when declared effective (it will include detailed transaction terms and voting instructions) and note that the board has authority, per the prior amendment proposal, to approve further one-month extensions up to six months without another shareholder vote.